This inventor holds 1 USPTO granted patent. Top assignee: Biochemie Gesellschaft M.b.h. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: The Innovations of Karl Wessely
Introduction
Karl Wessely is a notable inventor based in Kufstein, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin antibiotics. His work has led to advancements that benefit both the medical community and patients worldwide.
Latest Patents
Wessely holds a patent for a stable, crystalline form of a cephalosporin intermediate product. This invention relates to new stable, crystalline forms of the t-butylester of ceftazidime, which is crucial for enhancing the efficacy and stability of this antibiotic. The patent showcases his innovative approach to improving pharmaceutical formulations.
Career Highlights
Throughout his career, Wessely has been associated with Biochemie Gesellschaft M.b.h., a company known for its focus on biopharmaceuticals. His work at this organization has allowed him to collaborate with other experts in the field, furthering the development of important medical products.
Collaborations
Wessely has worked alongside notable colleagues such as Bernhard C. Prager and Werner Veit. Their combined expertise has contributed to the successful development of various pharmaceutical innovations.
Conclusion
Karl Wessely's contributions to the field of pharmaceuticals, particularly through his patent on cephalosporin intermediates, highlight his role as an influential inventor. His work continues to impact the medical field positively.